Table 3.
Studies comparing CBT-I to pharmacological therapies: follow-up results
| Study | Group | Sleep latency | Total sleep time | Total wake time | Efficiency | Other | Notes |
|---|---|---|---|---|---|---|---|
|
CBT-I vs. zopiclone |
|
|
|
|
|
SWS |
|
| Sievertsen 2006
[29] |
CBT-I: 18 |
Not reported |
–5.0 min |
–60.7 min |
+8.7% |
+21.1 min |
|
| Zopiclone :16 |
–56.2 min |
–9.9 min |
–0.4% |
–17.6 min |
|||
| 6 months |
|
p = NS |
p = 0.01 |
p = 0.008 |
p = 0.001 |
||
| Polysomnography | |||||||
| Sleep diary |
CBT-I: 18 |
Not reported |
+42.4 min |
–73.3 min |
+14.2% |
|
|
| Zopiclone :16 |
+40.5 min |
–42.2 min |
+10.7% |
||||
| |
p = NS |
p = 0.03 |
p = NS |
||||
|
CBT-I vs. zolpidem | |||||||
| Jacobs 2004
[30] |
CBT-I: 8 |
|
|
|
|
|
No long-term follow-up for zolpidem group |
| 12 months |
Zolpidem: none |
||||||
| Sleep diary | |||||||
|
CBT-I vs. temazepam |
WASO |
|
|||||
| Wu 2006
[31] |
CBT-I: 19 |
–32.8 min |
+30.3 min |
Not reported |
+10.2% |
|
p values based on post-intervention differences |
| 8 months |
Temazepam: 17 |
–17.2 min |
–13.0 min |
–1.9% |
|||
| Polysomnography |
|
p < 0.004 |
p < 0.05 |
p < 0.01 |
|||
| Sleep diary |
CBT-I: 19 |
–41.8 min |
45.5 min |
Not reported |
+16.8% |
||
| Temazepam: 17 |
–20.5 min |
–6.0 min |
+3.9% |
||||
| |
p < 0.003 |
p < 0.01 |
p < 0.05 |
||||
| Morin 1999
[31] |
CBT-I: 13 |
Not reported |
+65.2 min |
Not reported |
+16.4% |
–16.5 min |
All measurements in temazepam group significantly worsened from end of treatment to end of follow-up. |
| 24 months | |||||||
| Sleep diary |
Temazepam: 12 |
+11.5 min |
+2.9% |
–4.6 min |
|||
| |
p = NR |
p = NR |
p = NR |
||||
|
CBT-I vs. triazolam | |||||||
| McCluskey 1991
[33] |
CBT-I: 15 |
–45 min |
+51 min |
Not reported | Not reported | ||
| 8 weeks |
Triazolam :15 |
–21 min |
+14 min |
||||
| Sleep diary | p < 0.01 | p = NR | |||||
SWS Slow wave sleep, WASO Wake after sleep onset.